Michael Schmitz
Concepts (309)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiac Surgical Procedures | 8 | 2021 | 297 | 1.400 |
Why?
| Cefazolin | 2 | 2020 | 12 | 1.260 |
Why?
| Antibiotic Prophylaxis | 2 | 2020 | 61 | 1.220 |
Why?
| Heart Defects, Congenital | 8 | 2015 | 595 | 0.970 |
Why?
| Heart-Assist Devices | 6 | 2013 | 148 | 0.840 |
Why?
| Anti-Bacterial Agents | 2 | 2020 | 744 | 0.830 |
Why?
| Filtration | 1 | 2020 | 24 | 0.750 |
Why?
| Extracorporeal Membrane Oxygenation | 7 | 2016 | 287 | 0.740 |
Why?
| Masks | 1 | 2020 | 30 | 0.730 |
Why?
| Pulmonary Valve | 1 | 2021 | 46 | 0.730 |
Why?
| Cardiopulmonary Bypass | 7 | 2013 | 91 | 0.700 |
Why?
| Tetralogy of Fallot | 1 | 2021 | 86 | 0.700 |
Why?
| Neuralgia | 1 | 2021 | 62 | 0.700 |
Why?
| Catheterization, Central Venous | 3 | 2023 | 86 | 0.660 |
Why?
| Phlebotomy | 2 | 2016 | 4 | 0.650 |
Why?
| Lidocaine | 2 | 2016 | 49 | 0.630 |
Why?
| Catheterization, Peripheral | 2 | 2016 | 46 | 0.630 |
Why?
| Anesthetics, Local | 2 | 2016 | 75 | 0.620 |
Why?
| Heart Transplantation | 9 | 2012 | 312 | 0.510 |
Why?
| Renal Replacement Therapy | 1 | 2014 | 29 | 0.490 |
Why?
| Child, Preschool | 21 | 2020 | 3871 | 0.430 |
Why?
| Humans | 51 | 2023 | 49974 | 0.390 |
Why?
| Child | 18 | 2020 | 6847 | 0.380 |
Why?
| Acute Kidney Injury | 1 | 2014 | 284 | 0.380 |
Why?
| Adolescent | 16 | 2020 | 6356 | 0.380 |
Why?
| Tissue Donors | 3 | 2006 | 111 | 0.360 |
Why?
| Intraoperative Complications | 4 | 2010 | 112 | 0.350 |
Why?
| Heparin | 3 | 2013 | 92 | 0.340 |
Why?
| Cholesterol | 1 | 2009 | 146 | 0.330 |
Why?
| Pipecolic Acids | 1 | 2008 | 7 | 0.320 |
Why?
| Cerebral Hemorrhage | 1 | 2009 | 104 | 0.320 |
Why?
| Half-Life | 2 | 2020 | 84 | 0.310 |
Why?
| Brain Injuries | 3 | 2015 | 160 | 0.310 |
Why?
| Female | 28 | 2020 | 26472 | 0.310 |
Why?
| Area Under Curve | 2 | 2020 | 182 | 0.310 |
Why?
| Monte Carlo Method | 2 | 2020 | 84 | 0.300 |
Why?
| Thrombocytopenia | 1 | 2008 | 85 | 0.300 |
Why?
| Infant, Newborn | 15 | 2023 | 2772 | 0.300 |
Why?
| Anticoagulants | 3 | 2013 | 250 | 0.290 |
Why?
| Male | 27 | 2020 | 25241 | 0.290 |
Why?
| Body Weight | 3 | 2020 | 513 | 0.290 |
Why?
| Cardiac Output, High | 1 | 2006 | 3 | 0.270 |
Why?
| Laryngeal Masks | 1 | 2006 | 7 | 0.270 |
Why?
| Methyl Ethers | 1 | 2006 | 18 | 0.270 |
Why?
| Infant | 16 | 2018 | 3567 | 0.270 |
Why?
| Nitric Oxide | 3 | 2017 | 253 | 0.260 |
Why?
| Allied Health Personnel | 1 | 2006 | 25 | 0.260 |
Why?
| Facial Neoplasms | 1 | 2006 | 22 | 0.260 |
Why?
| Anesthetics, Inhalation | 1 | 2006 | 31 | 0.260 |
Why?
| Models, Biological | 2 | 2020 | 727 | 0.250 |
Why?
| Hemangioma | 1 | 2006 | 83 | 0.240 |
Why?
| Pain Management | 2 | 2016 | 160 | 0.240 |
Why?
| Heart Septal Defects, Atrial | 5 | 2012 | 44 | 0.240 |
Why?
| Heart Ventricles | 3 | 2021 | 249 | 0.220 |
Why?
| Subclavian Vein | 1 | 2003 | 10 | 0.220 |
Why?
| Central Venous Catheters | 1 | 2023 | 26 | 0.220 |
Why?
| Thoracotomy | 1 | 2003 | 34 | 0.220 |
Why?
| Brain | 4 | 2015 | 1328 | 0.210 |
Why?
| Scoliosis | 1 | 2003 | 59 | 0.210 |
Why?
| Treatment Outcome | 10 | 2017 | 5141 | 0.200 |
Why?
| Time Factors | 6 | 2018 | 2903 | 0.190 |
Why?
| Heparin Antagonists | 2 | 2013 | 7 | 0.190 |
Why?
| Protamines | 2 | 2013 | 8 | 0.190 |
Why?
| Sterilization | 1 | 2020 | 10 | 0.190 |
Why?
| Linear Models | 4 | 2016 | 280 | 0.190 |
Why?
| Metabolic Clearance Rate | 1 | 2020 | 68 | 0.190 |
Why?
| Hemodynamics | 2 | 2017 | 228 | 0.180 |
Why?
| Pain, Postoperative | 2 | 2016 | 158 | 0.180 |
Why?
| Surgical Procedures, Operative | 1 | 2020 | 63 | 0.180 |
Why?
| Pulmonary Artery | 1 | 2021 | 145 | 0.170 |
Why?
| Retrospective Studies | 10 | 2018 | 6108 | 0.170 |
Why?
| Occupational Exposure | 1 | 2020 | 122 | 0.170 |
Why?
| Dose-Response Relationship, Drug | 2 | 2020 | 1376 | 0.160 |
Why?
| Double-Blind Method | 3 | 2016 | 681 | 0.160 |
Why?
| Powders | 2 | 2016 | 26 | 0.160 |
Why?
| Needles | 2 | 2016 | 23 | 0.160 |
Why?
| Adult | 5 | 2021 | 13236 | 0.160 |
Why?
| Logistic Models | 3 | 2017 | 888 | 0.160 |
Why?
| Jugular Veins | 2 | 2023 | 30 | 0.160 |
Why?
| Chi-Square Distribution | 3 | 2014 | 280 | 0.160 |
Why?
| Heart Septal Defects, Ventricular | 2 | 2012 | 43 | 0.160 |
Why?
| Airway Extubation | 1 | 2018 | 30 | 0.160 |
Why?
| Databases, Factual | 3 | 2017 | 658 | 0.160 |
Why?
| Echocardiography, Transesophageal | 2 | 2012 | 60 | 0.150 |
Why?
| Multivariate Analysis | 3 | 2016 | 577 | 0.150 |
Why?
| Postoperative Care | 1 | 2018 | 102 | 0.150 |
Why?
| Pain Measurement | 2 | 2016 | 240 | 0.150 |
Why?
| Hospitals, Low-Volume | 1 | 2017 | 16 | 0.150 |
Why?
| Hospitals, High-Volume | 1 | 2017 | 25 | 0.150 |
Why?
| Off-Label Use | 1 | 2017 | 25 | 0.150 |
Why?
| Intubation, Intratracheal | 1 | 2018 | 118 | 0.150 |
Why?
| Williams Syndrome | 1 | 2017 | 27 | 0.140 |
Why?
| Heart Failure | 3 | 2012 | 458 | 0.140 |
Why?
| Shock | 1 | 2017 | 35 | 0.140 |
Why?
| Cardiovascular System | 1 | 2017 | 49 | 0.140 |
Why?
| Death, Sudden, Cardiac | 1 | 2017 | 53 | 0.140 |
Why?
| Pulmonary Circulation | 2 | 2014 | 33 | 0.140 |
Why?
| Pachyonychia Congenita | 1 | 2016 | 1 | 0.140 |
Why?
| Premedication | 1 | 2016 | 21 | 0.140 |
Why?
| Anesthesia | 1 | 2017 | 73 | 0.130 |
Why?
| Vasodilator Agents | 1 | 2016 | 96 | 0.130 |
Why?
| Foot | 1 | 2016 | 42 | 0.130 |
Why?
| Pandemics | 1 | 2020 | 559 | 0.130 |
Why?
| Hospital Mortality | 2 | 2014 | 409 | 0.130 |
Why?
| Administration, Cutaneous | 1 | 2015 | 51 | 0.130 |
Why?
| Reference Standards | 1 | 2015 | 56 | 0.130 |
Why?
| Quality of Life | 1 | 2021 | 836 | 0.120 |
Why?
| Hypertension, Pulmonary | 1 | 2016 | 114 | 0.120 |
Why?
| Blalock-Taussig Procedure | 1 | 2014 | 17 | 0.120 |
Why?
| Erythrocyte Transfusion | 1 | 2014 | 46 | 0.120 |
Why?
| Hypoxia-Ischemia, Brain | 1 | 2015 | 54 | 0.120 |
Why?
| Computer Simulation | 1 | 2015 | 280 | 0.120 |
Why?
| Embolism, Air | 2 | 2004 | 12 | 0.120 |
Why?
| Risk Factors | 4 | 2017 | 3613 | 0.110 |
Why?
| Young Adult | 2 | 2020 | 3958 | 0.110 |
Why?
| Chronic Pain | 1 | 2016 | 165 | 0.110 |
Why?
| Age Factors | 2 | 2014 | 1087 | 0.110 |
Why?
| Whole Blood Coagulation Time | 1 | 2013 | 6 | 0.110 |
Why?
| Odds Ratio | 1 | 2014 | 545 | 0.110 |
Why?
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2013 | 22 | 0.110 |
Why?
| Thrombelastography | 1 | 2013 | 24 | 0.110 |
Why?
| Brain Diseases | 1 | 2013 | 82 | 0.110 |
Why?
| Dexmedetomidine | 1 | 2012 | 21 | 0.100 |
Why?
| Pain | 1 | 2015 | 379 | 0.100 |
Why?
| Critical Illness | 1 | 2014 | 288 | 0.100 |
Why?
| Hypnotics and Sedatives | 1 | 2012 | 75 | 0.100 |
Why?
| Femoral Vein | 1 | 2012 | 40 | 0.100 |
Why?
| Hepacivirus | 1 | 2013 | 104 | 0.100 |
Why?
| Renal Artery | 1 | 2012 | 33 | 0.100 |
Why?
| Carotid Arteries | 1 | 2012 | 85 | 0.100 |
Why?
| Renal Circulation | 1 | 2012 | 59 | 0.100 |
Why?
| Hepatitis C, Chronic | 1 | 2013 | 83 | 0.100 |
Why?
| Career Choice | 1 | 2013 | 111 | 0.100 |
Why?
| Echocardiography, Doppler | 1 | 2012 | 53 | 0.100 |
Why?
| Ketamine | 1 | 2012 | 60 | 0.100 |
Why?
| Heart Diseases | 1 | 2014 | 206 | 0.100 |
Why?
| Femoral Artery | 1 | 2012 | 100 | 0.100 |
Why?
| Neuroprotective Agents | 1 | 2012 | 105 | 0.100 |
Why?
| Spherocytosis, Hereditary | 1 | 2010 | 14 | 0.090 |
Why?
| Anti-Inflammatory Agents | 1 | 2012 | 161 | 0.090 |
Why?
| United States | 3 | 2017 | 4860 | 0.090 |
Why?
| Aged | 3 | 2020 | 9310 | 0.090 |
Why?
| Lactates | 1 | 2010 | 29 | 0.090 |
Why?
| Tomography Scanners, X-Ray Computed | 1 | 2009 | 12 | 0.090 |
Why?
| Cardiac Output | 1 | 2009 | 34 | 0.090 |
Why?
| Child Nutrition Disorders | 1 | 2009 | 13 | 0.090 |
Why?
| Nutritional Support | 1 | 2009 | 34 | 0.090 |
Why?
| Cardiomyopathy, Dilated | 1 | 2009 | 35 | 0.080 |
Why?
| Equipment Failure | 1 | 2009 | 62 | 0.080 |
Why?
| Safety Management | 1 | 2009 | 38 | 0.080 |
Why?
| Dipyridamole | 1 | 2008 | 9 | 0.080 |
Why?
| Thrombin | 1 | 2008 | 38 | 0.080 |
Why?
| International Normalized Ratio | 1 | 2008 | 28 | 0.080 |
Why?
| Stroke | 1 | 2013 | 492 | 0.080 |
Why?
| Arkansas | 3 | 2013 | 1977 | 0.080 |
Why?
| Infusions, Intravenous | 1 | 2008 | 206 | 0.080 |
Why?
| Middle Aged | 2 | 2020 | 12069 | 0.080 |
Why?
| Drug Interactions | 1 | 2008 | 206 | 0.080 |
Why?
| Inflammation | 1 | 2012 | 604 | 0.080 |
Why?
| Feeding Methods | 1 | 2007 | 16 | 0.070 |
Why?
| Warfarin | 1 | 2008 | 86 | 0.070 |
Why?
| Quality Assurance, Health Care | 2 | 2009 | 149 | 0.070 |
Why?
| Sulfonamides | 1 | 2008 | 129 | 0.070 |
Why?
| Vena Cava, Superior | 1 | 2007 | 22 | 0.070 |
Why?
| Vocal Cord Paralysis | 1 | 2007 | 22 | 0.070 |
Why?
| Internship and Residency | 1 | 2013 | 443 | 0.070 |
Why?
| Length of Stay | 2 | 2008 | 619 | 0.070 |
Why?
| Aspirin | 1 | 2008 | 114 | 0.070 |
Why?
| Chronic Disease | 1 | 2009 | 567 | 0.070 |
Why?
| Arginine | 1 | 2008 | 179 | 0.070 |
Why?
| Platelet Aggregation Inhibitors | 1 | 2008 | 172 | 0.070 |
Why?
| Foreign Bodies | 1 | 2007 | 65 | 0.070 |
Why?
| Oximetry | 1 | 2007 | 67 | 0.070 |
Why?
| Oxygen Consumption | 1 | 2007 | 183 | 0.070 |
Why?
| Cerebrovascular Circulation | 1 | 2007 | 132 | 0.070 |
Why?
| Vincristine | 1 | 2006 | 89 | 0.070 |
Why?
| von Willebrand Diseases | 1 | 2006 | 22 | 0.070 |
Why?
| Cerebral Cortex | 1 | 2007 | 200 | 0.070 |
Why?
| Blood Coagulation Disorders | 1 | 2006 | 33 | 0.060 |
Why?
| Antineoplastic Agents, Phytogenic | 1 | 2006 | 69 | 0.060 |
Why?
| Prosthesis Implantation | 1 | 2005 | 44 | 0.060 |
Why?
| Vascular Surgical Procedures | 1 | 2007 | 165 | 0.060 |
Why?
| Analgesia | 1 | 2004 | 13 | 0.060 |
Why?
| Embolectomy | 1 | 2004 | 13 | 0.060 |
Why?
| Perioperative Care | 1 | 2004 | 41 | 0.060 |
Why?
| Combined Modality Therapy | 2 | 2016 | 637 | 0.060 |
Why?
| Follow-Up Studies | 5 | 2013 | 2182 | 0.060 |
Why?
| Hospitals, Pediatric | 1 | 2005 | 239 | 0.060 |
Why?
| Heart Arrest, Induced | 1 | 2004 | 7 | 0.060 |
Why?
| Advanced Cardiac Life Support | 1 | 2004 | 10 | 0.060 |
Why?
| Extracorporeal Circulation | 1 | 2004 | 9 | 0.060 |
Why?
| Heart Injuries | 1 | 2004 | 15 | 0.060 |
Why?
| Heart Septum | 1 | 2004 | 22 | 0.060 |
Why?
| Shock, Cardiogenic | 1 | 2004 | 25 | 0.060 |
Why?
| Esophagoscopy | 1 | 2004 | 27 | 0.060 |
Why?
| Esophageal Diseases | 1 | 2004 | 21 | 0.060 |
Why?
| Oxygenators, Membrane | 1 | 2003 | 3 | 0.060 |
Why?
| Diagnostic Imaging | 1 | 2005 | 176 | 0.060 |
Why?
| Tissue and Organ Procurement | 1 | 2004 | 39 | 0.060 |
Why?
| Cattle | 1 | 2004 | 210 | 0.060 |
Why?
| Esophagus | 1 | 2004 | 84 | 0.060 |
Why?
| Catheters, Indwelling | 1 | 2023 | 58 | 0.060 |
Why?
| Pleural Cavity | 1 | 2003 | 3 | 0.060 |
Why?
| Necrosis | 1 | 2023 | 176 | 0.050 |
Why?
| Pulmonary Embolism | 1 | 2004 | 97 | 0.050 |
Why?
| Wounds, Nonpenetrating | 1 | 2004 | 81 | 0.050 |
Why?
| Incidence | 2 | 2018 | 1003 | 0.050 |
Why?
| Edema | 1 | 2023 | 67 | 0.050 |
Why?
| Cognition Disorders | 1 | 2004 | 218 | 0.050 |
Why?
| Postoperative Period | 2 | 2017 | 170 | 0.050 |
Why?
| Prospective Studies | 3 | 2014 | 2364 | 0.050 |
Why?
| Ultrasonography | 3 | 2012 | 436 | 0.050 |
Why?
| Magnetic Resonance Imaging | 3 | 2015 | 1537 | 0.050 |
Why?
| Fontan Procedure | 1 | 2002 | 64 | 0.050 |
Why?
| Radiography | 1 | 2003 | 489 | 0.050 |
Why?
| Athletic Injuries | 1 | 2004 | 191 | 0.050 |
Why?
| Pneumonia, Viral | 1 | 2004 | 168 | 0.050 |
Why?
| Heart | 1 | 2004 | 326 | 0.050 |
Why?
| Pilot Projects | 2 | 2014 | 699 | 0.050 |
Why?
| Regression Analysis | 2 | 2013 | 395 | 0.050 |
Why?
| Spectroscopy, Near-Infrared | 2 | 2012 | 53 | 0.040 |
Why?
| Analgesics, Opioid | 1 | 2004 | 552 | 0.040 |
Why?
| Cardiac Catheterization | 2 | 2012 | 201 | 0.040 |
Why?
| Administration, Inhalation | 1 | 2016 | 107 | 0.030 |
Why?
| Illinois | 1 | 2016 | 11 | 0.030 |
Why?
| Placebo Effect | 1 | 2016 | 17 | 0.030 |
Why?
| Drug Compounding | 1 | 2016 | 24 | 0.030 |
Why?
| Administration, Topical | 1 | 2016 | 56 | 0.030 |
Why?
| Hematocrit | 1 | 2014 | 44 | 0.030 |
Why?
| Anisotropy | 1 | 2014 | 63 | 0.030 |
Why?
| Survival Rate | 1 | 2016 | 894 | 0.030 |
Why?
| Preoperative Care | 1 | 2015 | 164 | 0.030 |
Why?
| Equipment Design | 2 | 2005 | 284 | 0.030 |
Why?
| Diffusion Tensor Imaging | 1 | 2014 | 91 | 0.030 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2014 | 123 | 0.030 |
Why?
| Electroencephalography | 1 | 2015 | 306 | 0.030 |
Why?
| Case Management | 1 | 2013 | 43 | 0.030 |
Why?
| Intention to Treat Analysis | 1 | 2012 | 27 | 0.030 |
Why?
| Hip | 1 | 2012 | 25 | 0.030 |
Why?
| Statistics, Nonparametric | 1 | 2012 | 194 | 0.030 |
Why?
| Risk Assessment | 1 | 2017 | 1259 | 0.030 |
Why?
| Pulsatile Flow | 1 | 2012 | 18 | 0.030 |
Why?
| Rotation | 1 | 2012 | 45 | 0.030 |
Why?
| Prosthesis Design | 1 | 2013 | 237 | 0.030 |
Why?
| Patient Positioning | 1 | 2012 | 32 | 0.030 |
Why?
| Vascular Resistance | 1 | 2012 | 54 | 0.030 |
Why?
| Injections, Intravenous | 1 | 2012 | 140 | 0.030 |
Why?
| Body Height | 1 | 2012 | 65 | 0.030 |
Why?
| Regional Blood Flow | 1 | 2012 | 108 | 0.030 |
Why?
| Septal Occluder Device | 1 | 2012 | 31 | 0.030 |
Why?
| Blood Flow Velocity | 1 | 2012 | 101 | 0.030 |
Why?
| Patient Safety | 1 | 2012 | 102 | 0.020 |
Why?
| Central Nervous System | 1 | 2012 | 85 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 2012 | 376 | 0.020 |
Why?
| C-Reactive Protein | 1 | 2012 | 142 | 0.020 |
Why?
| Hematologic Tests | 1 | 2010 | 10 | 0.020 |
Why?
| Gestational Age | 1 | 2012 | 421 | 0.020 |
Why?
| Feasibility Studies | 1 | 2012 | 375 | 0.020 |
Why?
| Child Development | 1 | 2012 | 190 | 0.020 |
Why?
| Prevalence | 1 | 2013 | 944 | 0.020 |
Why?
| Severity of Illness Index | 1 | 2013 | 945 | 0.020 |
Why?
| Case-Control Studies | 1 | 2012 | 1131 | 0.020 |
Why?
| Predictive Value of Tests | 1 | 2012 | 903 | 0.020 |
Why?
| Infant, Premature | 1 | 2012 | 318 | 0.020 |
Why?
| Anesthesia, General | 1 | 2010 | 91 | 0.020 |
Why?
| Cytokines | 1 | 2012 | 612 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2016 | 3129 | 0.020 |
Why?
| Prognosis | 1 | 2013 | 1942 | 0.020 |
Why?
| Cohort Studies | 1 | 2012 | 1422 | 0.020 |
Why?
| Intubation, Gastrointestinal | 1 | 2007 | 27 | 0.020 |
Why?
| Gastrostomy | 1 | 2007 | 55 | 0.020 |
Why?
| Laryngoscopy | 1 | 2007 | 58 | 0.020 |
Why?
| Aorta, Thoracic | 1 | 2007 | 92 | 0.020 |
Why?
| Tracheostomy | 1 | 2007 | 75 | 0.020 |
Why?
| Coagulants | 1 | 2006 | 3 | 0.020 |
Why?
| Factor VIII | 1 | 2006 | 23 | 0.020 |
Why?
| Atrial Flutter | 1 | 2005 | 8 | 0.020 |
Why?
| Postoperative Hemorrhage | 1 | 2006 | 51 | 0.020 |
Why?
| Cyanosis | 1 | 2004 | 18 | 0.020 |
Why?
| Ventilation-Perfusion Ratio | 1 | 2004 | 6 | 0.020 |
Why?
| Ligation | 1 | 2004 | 59 | 0.020 |
Why?
| Emergencies | 1 | 2004 | 86 | 0.010 |
Why?
| Enoxaparin | 1 | 2004 | 27 | 0.010 |
Why?
| Ventricular Outflow Obstruction | 1 | 2004 | 23 | 0.010 |
Why?
| Arm | 1 | 2004 | 47 | 0.010 |
Why?
| Hypopharynx | 1 | 2004 | 4 | 0.010 |
Why?
| Cardioplegic Solutions | 1 | 2004 | 3 | 0.010 |
Why?
| Infarction, Middle Cerebral Artery | 1 | 2004 | 40 | 0.010 |
Why?
| Ductus Arteriosus, Patent | 1 | 2004 | 38 | 0.010 |
Why?
| Mucous Membrane | 1 | 2004 | 28 | 0.010 |
Why?
| Suture Techniques | 1 | 2004 | 59 | 0.010 |
Why?
| Risk | 1 | 2004 | 320 | 0.010 |
Why?
| Equipment Failure Analysis | 1 | 2003 | 46 | 0.010 |
Why?
| Veins | 1 | 2004 | 71 | 0.010 |
Why?
| Ischemia | 1 | 2004 | 153 | 0.010 |
Why?
| Pressure | 1 | 2003 | 105 | 0.010 |
Why?
| Monitoring, Physiologic | 1 | 2004 | 120 | 0.010 |
Why?
| Coronary Artery Bypass | 1 | 2004 | 118 | 0.010 |
Why?
| Tricuspid Atresia | 1 | 2002 | 12 | 0.010 |
Why?
| Pulmonary Atresia | 1 | 2002 | 23 | 0.010 |
Why?
| Palliative Care | 1 | 2004 | 187 | 0.010 |
Why?
| Blood Vessel Prosthesis Implantation | 1 | 2004 | 120 | 0.010 |
Why?
| Drug Delivery Systems | 1 | 2004 | 138 | 0.010 |
Why?
| Sepsis | 1 | 2004 | 220 | 0.010 |
Why?
| Blood Pressure | 1 | 2003 | 512 | 0.010 |
Why?
| Diagnosis, Differential | 1 | 2004 | 1037 | 0.010 |
Why?
| Algorithms | 1 | 2003 | 615 | 0.010 |
Why?
| Postoperative Complications | 1 | 2002 | 984 | 0.010 |
Why?
| Animals | 1 | 2004 | 13187 | 0.010 |
Why?
|
|
Schmitz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|